BDRX
Biodexa·NASDAQ
--
--(--)
--
--(--)
BDRX fundamentals
During FY 2025, Biodexa (BDRX) reported revenue of 0, a YoY change of 0.00%. Net income was -8.58M, a YoY change of -19.67%. Click to view the full income statement and explore the company's earnings performance.
Income Statement
H1,2015 | FY,2015 | FY,2016 | H1,2017 | FY,2017 | H1,2018 | FY,2018 | FY,2019 | H1,2020 | FY,2020 | H1,2021 | FY,2021 | H1,2022 | FY,2022 | H1,2023 | FY,2023 | H1,2024 | FY,2024 | H1,2025 | FY,2025 | TTM |
|---|
Start Date | Jan 1, 2015 | Jan 1, 2015 | Jan 1, 2016 | Jan 1, 2017 | Jan 1, 2017 | Jan 1, 2018 | Jan 1, 2018 | Jan 1, 2019 | Jan 1, 2020 | Jan 1, 2020 | Jan 1, 2021 | Jan 1, 2021 | Jan 1, 2022 | Jan 1, 2022 | Jan 1, 2023 | Jan 1, 2023 | Jan 1, 2024 | Jan 1, 2024 | Jan 1, 2025 | Jan 1, 2025 | -- |
End Date | Jun 30, 2015 | Dec 31, 2015 | Dec 31, 2016 | Jun 30, 2017 | Dec 31, 2017 | Jun 30, 2018 | Dec 31, 2018 | Dec 31, 2019 | Jun 30, 2020 | Dec 31, 2020 | Jun 30, 2021 | Dec 31, 2021 | Jun 30, 2022 | Dec 31, 2022 | Jun 30, 2023 | Dec 31, 2023 | Jun 30, 2024 | Dec 31, 2024 | Jun 30, 2025 | Dec 31, 2025 | -- |
Fiscal Year-End | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | -- |
Revenue | 509.55K -- | 2.03M -- | 1.63M -19.50% | 614.66K -- | 1.34M -18.02% | 724.52K +17.87% | 2.47M +84.86% | 894.33K -63.84% | 207.80K -- | 468.61K -47.60% | 553.62K +166.42% | 780.30K +66.51% | 569.18K +2.81% | 844.18K +8.19% | 378.73K -33.46% | 485.51K -42.49% | -- -- | 0 -100.00% | -- -- | 0 -- | -- -- |
Sales and Services Revenue | 509.55K -- | 2.03M -- | 1.63M -19.50% | 614.66K -- | 1.34M -18.02% | 724.52K +17.87% | 2.47M +84.86% | 894.33K -63.84% | 207.80K -- | 468.61K -47.60% | 553.62K +166.42% | 780.30K +66.51% | 569.18K +2.81% | 844.18K +8.19% | 378.73K -33.46% | 485.51K -42.49% | 0 -100.00% | 0 -100.00% | 0 -- | 0 -- | -- -- |
Cost of Revenue | -- -- | 103.22K -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Gross Profit | 509.55K -- | 1.92M -- | 1.63M -15.18% | 614.66K -- | 1.34M -18.02% | 724.52K +17.87% | 2.47M +84.86% | 894.33K -63.84% | 207.80K -- | -- -- | 553.62K +166.42% | -- -- | 569.18K +2.81% | -- -- | 378.73K -33.46% | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Other Operating Income | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 16.39K -- | -- -- | 32.40K +97.63% | -- -- | 26.57K -18.00% | -- -- | 17.84K -32.85% | 0 -- | 38.82K +117.57% | 37.05K -- | 204.39K +426.58% | 204.39K -- |
Operating Expenses | 8.79M -- | 20.97M -- | 13.54M -35.44% | 9.23M -- | 19.30M +42.54% | 9.00M -2.55% | 17.55M -9.05% | 15.91M -9.35% | 22.90M -- | 31.96M +100.87% | 5.02M -78.08% | 10.26M -67.90% | 5.16M +2.90% | 11.66M +13.63% | 5.77M +11.78% | 10.72M -8.08% | 5.34M -7.53% | 11.56M +7.85% | 5.55M +3.93% | 11.83M +2.36% | 11.83M -- |
Selling, General and Administrative Expenses | 5.93M -- | 8.13M -- | 4.00M -50.76% | 3.81M -- | 6.00M +49.91% | 2.94M -23.05% | 5.61M -6.56% | 5.53M -1.48% | 3.63M -- | 6.77M +22.59% | 2.29M -36.98% | 3.98M -41.29% | 2.25M -1.64% | 5.49M +37.92% | 2.91M +29.48% | 5.53M +0.87% | 2.57M -11.70% | 4.75M -14.17% | 3.26M +26.92% | 6.50M +36.93% | 6.50M -- |
General and Administrative Expenses | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 6.77M -- | -- -- | 3.98M -41.29% | -- -- | 5.49M +37.92% | -- -- | 5.53M +0.87% | 2.57M -- | 4.75M -14.17% | 3.26M +26.92% | 6.50M +36.93% | 6.50M -- |
Research and Development Expenses | 2.87M -- | 12.84M -- | 9.54M -25.75% | 5.42M -- | 11.27M +18.16% | 6.06M +11.88% | 11.94M +6.00% | 10.41M -12.88% | 4.93M -- | 8.29M -20.34% | 2.78M -43.76% | 6.28M -24.21% | 2.93M +5.75% | 6.17M -1.76% | 2.86M -2.52% | 5.18M -16.04% | 2.77M -3.28% | 6.81M +31.36% | 2.28M -17.43% | 5.33M -21.76% | 5.33M -- |
Loss on Impairment of Other Assets | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 16.90M -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Other Operating Expenses | -- -- | -- -- | -- -- | -- -- | 2.03M -- | -- -- | -- -- | -19.90K -- | 14.34M -- | -- -- | -42.80K -100.30% | -- -- | -19.46K +54.53% | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Operating Income | -8.28M -- | -19.05M -- | -11.91M +37.49% | -8.62M -- | -17.96M -50.84% | -8.27M +4.00% | -15.08M +16.04% | -15.02M +0.41% | -22.69M -- | -31.48M -109.60% | -4.46M +80.32% | -9.45M +69.99% | -4.59M -2.91% | -10.79M -14.18% | -5.39M -17.39% | -10.21M +5.33% | -5.34M +1.04% | -11.52M -12.79% | -5.51M -3.24% | -11.62M -0.93% | -11.62M -- |
Non-Operating Income (Loss) | 25.16K -- | 2.49M -- | 1.56M -37.28% | -61.08K -- | 413.99K -73.45% | -315.41K -416.42% | -746.64K -280.35% | 524.13K +170.20% | 601.13K -- | -587.47K -212.08% | -215.37K -135.83% | 1.20M +304.98% | 462.16K +314.58% | 536.22K -55.47% | 493.11K +6.70% | 674.10K +25.71% | 998.56K +102.50% | 4.03M +498.09% | 61.75K -93.82% | 2.90M -28.09% | 2.90M -- |
Other Non-Operating Income (Loss) | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -542.38K -- | -- -- | -- -- | -- -- | -12.08K -- | -- -- | -- -- | 0 -- | -- -- | -59.00K -- | -- -- | -- -- |
Net Interest Expense | -25.16K -- | -2.49M -- | -1.56M +37.28% | 61.08K -- | -413.99K +73.45% | 315.41K +416.42% | 746.64K +280.35% | -524.13K -170.20% | -601.13K -- | 45.08K +108.60% | 215.37K +135.83% | -1.20M -2770.98% | -462.16K -314.58% | -548.30K +54.47% | -493.11K -6.70% | -674.10K -22.95% | -998.56K -102.50% | -4.03M -498.09% | -120.75K +87.91% | -2.90M +28.09% | -2.90M -- |
Interest Expense | 18.87K -- | 7.37K -- | 90.06K +1121.49% | 79.27K -- | 147.47K +63.74% | 316.73K +299.56% | 749.19K +408.04% | 128.71K -82.82% | 27.21K -- | 46.45K -63.91% | 215.37K +691.47% | 59.40K +27.88% | 29.19K -86.45% | 51.93K -12.57% | 27.96K -4.21% | 52.25K +0.61% | 61.94K +121.52% | 206.60K +295.43% | 126.24K +103.83% | 307.94K +49.05% | 307.94K -- |
Interest Income | 44.04K -- | 2.49M -- | 1.65M -33.85% | 18.19K -- | 561.45K -65.96% | 1.32K -92.75% | 2.55K -99.55% | 652.83K +25475.29% | 628.35K -- | 1.37K -99.79% | -- -- | 1.26M +92390.12% | 491.34K -- | 600.23K -52.50% | 521.07K +6.05% | 726.35K +21.01% | 1.06M +103.52% | 4.24M +483.51% | 247.00K -76.71% | 3.21M -24.33% | 3.21M -- |
Pretax Income From Continuing Operations | -8.26M -- | -16.56M -- | -10.35M +37.52% | -8.68M -- | -17.55M -69.57% | -8.59M +1.05% | -15.83M +9.81% | -14.49M +8.42% | -22.09M -- | -32.06M -121.23% | -4.68M +78.81% | -8.24M +74.29% | -4.13M +11.70% | -10.25M -24.36% | -4.90M -18.58% | -9.54M +6.95% | -4.34M +11.45% | -7.49M +21.51% | -5.45M -25.57% | -8.73M -16.56% | -8.73M -- |
Income Tax Expense | -559.88K -- | -1.67M -- | -2.75M -64.45% | -836.88K -- | -1.71M +37.71% | -1.17M -40.19% | -2.59M -51.54% | -2.37M +8.67% | -543.00K -- | -1.75M +26.11% | -325.82K +40.00% | -872.10K +50.17% | -409.86K -25.79% | -1.00M -15.22% | -366.02K +10.70% | -517.37K +48.51% | -158.00K +56.83% | -313.02K +39.50% | -226.41K -43.30% | -141.19K +54.89% | -141.19K -- |
Current Income Tax | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -1.75M -- | -- -- | -872.10K +50.17% | -- -- | -1.00M -15.22% | -- -- | -518.64K +48.38% | -- -- | -301.76K +41.82% | -- -- | 28.24K +109.36% | 28.24K -- |
Deferred Income Tax | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 0 -- | -- -- | 0 -- | -- -- | 0 -- | -- -- | 0 -- | -- -- | 0 -- | -- -- | 0 -- | -- -- |
Income Tax Adjustments | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 1.27K -- | -- -- | -11.27K -984.32% | -- -- | -169.43K -1403.54% | -169.43K -- |
Income from Discontinued Operations | -- -- | -- -- | -17.27M -- | -3.90M -- | -5.90M +65.86% | -7.65M -96.23% | -5.95M -0.90% | -1.26M +78.88% | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Net Income | -7.70M -- | -14.89M -- | -24.87M -67.03% | -11.74M -- | -21.73M +12.63% | -15.06M -28.30% | -19.18M +11.73% | -13.38M +30.24% | -21.55M -- | -30.31M -126.54% | -4.35M +79.79% | -7.37M +75.68% | -3.72M +14.51% | -9.25M -25.44% | -4.53M -21.81% | -9.02M +2.44% | -4.18M +7.79% | -7.17M +20.48% | -5.22M -24.90% | -8.58M -19.67% | -8.58M -- |
Net Income Attributable to Owners of the Company | -7.70M -- | -14.89M -- | -24.87M -67.03% | -11.74M -- | -21.73M +12.63% | -15.06M -28.30% | -19.18M +11.73% | -13.38M +30.24% | -21.55M -- | -30.31M -126.54% | -4.35M +79.79% | -7.37M +75.68% | -3.72M +14.51% | -9.25M -25.44% | -4.53M -21.81% | -9.02M +2.44% | -4.18M +7.79% | -7.17M +20.48% | -5.22M -24.90% | -8.58M -19.67% | -8.58M -- |
Net Income Attributable to Common Stockholders | -7.70M -- | -14.89M -- | -24.87M -67.03% | -11.74M -- | -21.73M +12.63% | -15.06M -28.30% | -19.18M +11.73% | -13.38M +30.24% | -21.55M -- | -30.31M -126.54% | -4.35M +79.79% | -7.37M +75.68% | -3.72M +14.51% | -9.25M -25.44% | -4.53M -21.81% | -9.02M +2.44% | -4.18M +7.79% | -7.17M +20.48% | -5.22M -24.90% | -8.58M -19.67% | -8.58M -- |
Other Comprehensive Income | -94.36K -- | 588.37K -- | 3.98M +576.86% | -192.33K -- | -1.67M -141.89% | 269.22K +239.98% | -3.43M -105.51% | -274.67K +91.99% | 176.88K -- | 694.03K +352.68% | -- -- | -- -- | -- -- | -- -- | -- -- | 0 -- | -- -- | 0 -- | 4.12K -- | 4.03K -- | 4.03K -- |
Total Comprehensive Income | -7.79M -- | -14.30M -- | -20.89M -46.06% | -11.93M -- | -23.40M -12.01% | -14.79M -23.97% | -22.61M +3.38% | -13.66M +39.60% | -21.37M -- | -29.62M -116.90% | -4.35M +79.62% | -- -- | -3.72M +14.51% | -9.25M -- | -4.53M -21.81% | -9.02M +2.44% | -4.18M +7.79% | -7.17M +20.48% | -5.22M -24.80% | -8.58M -19.62% | -8.58M -- |
Total Comprehensive Income Attributable to Owners of the Company | -7.79M -- | -14.30M -- | -20.89M -46.06% | -11.93M -- | -23.40M -12.01% | -14.79M -23.97% | -22.61M +3.38% | -13.66M +39.60% | -21.37M -- | -29.62M -116.90% | -4.35M +79.62% | -7.37M +75.12% | -3.72M +14.51% | -9.25M -25.44% | -4.53M -21.81% | -9.02M +2.44% | -4.18M +7.79% | -7.17M +20.48% | -5.22M -24.80% | -8.58M -19.62% | -8.58M -- |
Basic EPS | -0.28 -- | -0.53 -- | -0.69 -30.19% | -0.16 -- | -8.47 -1127.54% | -0.12 +25.00% | -6.28 +25.86% | -0.73 +88.38% | -0.79 -- | -14.15 -1838.36% | -0.07 +91.14% | -1.84 +87.00% | -0.75 -971.43% | -1.87 -1.63% | -0.05 +93.33% | -0.03 +98.40% | 0 +100.00% | 0 +100.00% | 0 -- | 0 -- | -- -- |
Basic EPS from Continuing Operations | -- -- | -- -- | -0.21 -- | -- -- | -6.17 -2838.10% | -- -- | -4.33 +29.82% | -0.66 +84.76% | -- -- | -14.15 -2043.94% | -- -- | -1.84 +87.00% | -- -- | -1.87 -1.63% | -- -- | -0.03 +98.40% | 0 -- | -1.25 -4066.67% | 0 -- | 0 +100.00% | -- -- |
Basic EPS from Discontinued Operations | -- -- | -- -- | -0.48 -- | -- -- | -2.3 -379.17% | -- -- | -1.95 +15.22% | -0.07 +96.41% | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Diluted EPS | -0.28 -- | -0.53 -- | -0.69 -30.19% | -0.16 -- | -8.47 -1127.54% | -0.12 +25.00% | -6.28 +25.86% | -0.73 +88.38% | -0.79 -- | -14.15 -1838.36% | -0.07 +91.14% | -1.84 +87.00% | -0.75 -971.43% | -1.87 -1.63% | -0.05 +93.33% | -0.03 +98.40% | 0 +100.00% | 0 +100.00% | 0 -- | 0 -- | -- -- |
Diluted EPS from Continuing Operations | -- -- | -- -- | -0.21 -- | -- -- | -6.17 -2838.10% | -- -- | -4.33 +29.82% | -0.66 +84.76% | -- -- | -14.15 -2043.94% | -- -- | -1.84 +87.00% | -- -- | -1.87 -1.63% | -- -- | -0.03 +98.40% | 0 -- | -1.25 -4066.67% | 0 -- | 0 +100.00% | -- -- |
Diluted EPS from Discontinued Operations | -- -- | -- -- | -0.48 -- | -- -- | -2.3 -379.17% | -- -- | -1.95 +15.22% | -0.07 +96.41% | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
You can ask Aime
Did Biodexa beat or miss consensus estimates last quarter?What guidance did Biodexa's management provide for the next earnings period?What is the market's earnings forecast for Biodexa next quarter?What is Biodexa's gross profit margin?What were the key takeaways from Biodexa’s earnings call?What factors drove the changes in Biodexa's revenue and profit?What does Biodexa do and what are its main business segments?What were the key takeaways from Biodexa's earnings call?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
